Companies

BioLineRx Ltd

NASDAQ: BLRX
$1.02
▼ $0.04 (−3.76%) today
Markets open · 1:27pm ET

BLRX at a Glance

Earnings
Next report
Nov 23, 2026

NASDAQ: BLRX

About BioLineRx

BioLineRx is a biopharmaceutical company focused on developing therapies in oncology and rare diseases. Its first approved product, APHEXDA (motixafortide), is a novel peptide approved in the U.S. for stem cell mobilization for autologous transplantation in multiple myeloma patients, now commercialized by Ayrmid Pharma (globally, excluding Asia) and Guangzhou Gloria Biosciences (in Asia) under out-licensing agreements. BioLineRx retains rights to develop motixafortide across all solid tumor indications outside of Asia, including pancreatic cancer, where a Phase 2b randomized study is ongoing in collaboration with Regeneron and Columbia University. The company is also advancing GLIX1, a first-in-class oral small molecule targeting DNA damage response in glioblastoma and other cancers, through a collaboration with Hemispherian AS. GLIX1 entered a first-in-human Phase 1/2 clinical trial in April 2026 and holds Orphan Drug Designation from both the FDA and EMA. BioLineRx's strategy centers on in-licensing innovative assets with back-ended, success-based deal structures and funding development through royalties and milestones from its existing partnerships. The company also markets BL-5010, a legacy skin lesion removal product out-licensed to Perrigo for OTC use in Europe. BioLineRx trades on Nasdaq as ADSs, with each ADS representing 600 ordinary shares. Updated

Latest Activity

Earnings on deck — Nov 23–27
73 companies43 before open30 after close

Thanksgiving week crams 73 reporters into three trading days, and Monday after the close is where it all lands: Hewlett Packard Enterprise, Zoom, Agilent, Symbotic, Fluence Energy and Semtech all report the same evening. That single block covers enterprise spending, AI infrastructure and industrial demand before liquidity thins out.

  • VNETVNET Group, Inc.Mon Nov 23Before open
  • BLRXBioLineRx Ltd.Mon Nov 23Before open
  • CRGOFreightos LimitedMon Nov 23Before open
  • THCHTims ChinaMon Nov 23Before open
  • TUYATuya Inc.Mon Nov 23After close
  • HPEHewlett Packard EnterpriseMon Nov 23After close
  • SYMSymbotic Inc. Mon Nov 23After close
  • JJacobs Solutions Inc.Mon Nov 23After close
  • AAgilent Technologies, Inc.Mon Nov 23After close
  • ALCOAlico Inc.Mon Nov 23After close
  • FLNCFluence Energy, Inc.Mon Nov 23After close
  • SMTCSemtech CorporationMon Nov 23After close
  • ZMZoom Communications, Inc.Mon Nov 23After close
  • CENTCentral Garden & Pet CompanyMon Nov 23After close
  • CMPCompass Minerals International, Inc.Mon Nov 23After close

BLRX Coverage

Frequently Asked Questions

What does BioLineRx do?

BioLineRx is a biopharmaceutical company focused on developing therapies in oncology and rare diseases.